Lai Fengting, L. H. (2023). Clinical efficacy of camrelizumab combined with lunvatinib or bevacizumab in the treatment of hepatocellular carcinoma. Editorial Office of Journal of New Medicine.
Chicago Style (17th ed.) CitationLai Fengting, Liu Huaqiang. Clinical Efficacy of Camrelizumab Combined with Lunvatinib or Bevacizumab in the Treatment of Hepatocellular Carcinoma. Editorial Office of Journal of New Medicine, 2023.
MLA (9th ed.) CitationLai Fengting, Liu Huaqiang. Clinical Efficacy of Camrelizumab Combined with Lunvatinib or Bevacizumab in the Treatment of Hepatocellular Carcinoma. Editorial Office of Journal of New Medicine, 2023.
Warning: These citations may not always be 100% accurate.